March 2020 – BioHealth Capital Region
COVID-19 Vaccines: Global Health Issues
Biomedicines | Free Full-Text | Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
Vaxart, Inc. – SEC Filing
Webinar: The Quest for a COVID-19 Vaccine | The New York Academy of Sciences
avir20170630_10k.htm
avir20170630_10k.htm
Vaxart Has Developed the First Oral Investigational COVID-19 Vaccine
COVID-19 tracker: Omicron booster nods expected Wednesday
avir20170630_10k.htm
Vaccines | Free Full-Text | COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
COVID-19 vaccines: where we stand and challenges ahead | Cell Death & Differentiation
Vaxart Stock: Investment Case For An Oral COVID Vaccine (NASDAQ:VXRT) | Seeking Alpha
Articles with Vaxart, Inc.
Vaxart appoints first general counsel | Corporate Secretary
Bioengineering | Free Full-Text | COVID-19 Vaccines: An Overview of Different Platforms
Articles with Vaxart, Inc.
Vaxart, Inc. – SEC Filing
Vaxart, Inc. – SEC Filing
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
